Stryker Shares Slide 0.62% as Trading Volume Plummets to $340M Ranking 301st in Market Activity

On September 24, 2025, Stryker (SYK) closed at a 0.62% decline, with trading volume shrinking 50.57% to $340 million, ranking 301st in market activity among listed stocks. The underperformance followed mixed signals from regulatory and operational developments in the medical devices sector.

Recent reports highlighted Stryker’s ongoing challenges with product recalls and supply chain bottlenecks, which have dampened investor sentiment. A key FDA inspection delay for a flagship orthopedic device line raised concerns over potential revenue disruptions. Meanwhile, analysts noted that the company’s recent partnership with a European distributor remains unproven in boosting market share, limiting upside momentum.

Market participants remain cautious as Stryker navigates a competitive landscape marked by pricing pressures and patent expirations. Institutional investors reduced exposure ahead of anticipated quarterly earnings, contributing to the volume contraction. Technical indicators suggest short-term volatility may persist amid unresolved regulatory uncertainties.

To run this back-test I’ll need to pin down a couple of practical details so the signals can be built correctly: 1. Stock universe • Do you want all U.S. listed equities, or a defined benchmark universe such as the S&P 500, Russell 3000, etc.? • (If you choose “all U.S. equities,” note that our data interface will include roughly 6-7 K tickers.) 2. Weighting & rebalancing • Should the 500 selected names each day be held in equal weights, or weighted by something else (e.g., proportional to volume)? • Confirm that rebalancing happens every trading day: buy at the close (or open?) of day t, sell at the close of day t + 1. 3. Trading frictions • Do you want to include any estimates for commissions or slippage? With those items confirmed I can generate the selection signals and run the back-test from 2022-01-03 (first trading day) through today.